Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 1. Fermentation and biological characteristics

Journal of Antibiotics

Volumn 54, Issue 2, 2001, Pages 149-152

  Fudou, R ^a   Iizuka, T ^a   Yamanaka, S ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID DERIVATIVE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYTOCHROME B; CYTOCHROME C OXIDASE; CYTOCHROME C1; HALIANGICIN; MYXOTHIAZOL; NEW DRUG; NYSTATIN; POLYENE ANTIBIOTIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RESIN; SEA WATER; SODIUM CHLORIDE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; AQUATIC FAUNA; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG CONJUGATION; DRUG DECOMPOSITION; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON TRANSPORT; FUNGUS CULTURE; METABOLITE; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRION; MOUSE; MYXOCOCCALES; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY CHAIN; STRUCTURE ANALYSIS;

HALIANGIUM LUTEUM;

EID: 0035083728     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.54.149     Document Type: Article

References (12)

1. Myxobacteria: A source of new antibiotics
2. Myxobacteria II, Production of secondary metabolites
3. Drug discovery from nature, Myxobacteria as producers of secondary metabolites
4. Isolation of myxobacteria from the marine environment
5. Polyene antibiotic SMP-2 and its photoisomers and antifungal agents containing it
6. Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 2. Isolation and structural elucidation
7. Myxothiazol, a new inhibitor of the cytochrome b-cl segment of the respiratory chain
8. The strobirulins, oudemansins and myxothiazols, fungicidal derivatives of β-methoxyacrylic acid
9. Oudemansin, strobilurin B and myxothiazol: New inhibitors of the bcl segment of the respiratory chain with an α-β-methoxyacrylate system as common structural element
10. Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium, Cystobacter fuscus
11. Melithiazols, new β-methoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria
12. The mode of action of stigmatellin, a new inhibitor of the cytochrome b-cl segment of the respiratory chain